StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Consolidated Organic Revenue Growth by Year

Consolidated Organic Revenue Growth (%)

Thermo Fisher Scientific Consolidated Organic Revenue Growth: 2.0% in FY2025, up 2.0 pts from a year earlier.

Latest, FY2025
2.0%
Period ended Dec 31, 2025
Change on a year earlier
+2.0 pts
0.0% in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below

Where the FY2025 figure comes from

“Organic revenue growth (non-GAAP measure) -5% 0% 2%”

Source: Q3 2026 Reconciliation of Financial Information ↗

The key operating metric used by management for quarterly guidance and operational tracking, excluding M&A impacts and foreign exchange fluctuations.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated Organic Revenue Growth (%)Year on yearSource
FY2025Dec 31, 20252.0%+2.0 ptsQ3 2026 Reconciliation of Financial Information ↗
FY2024Dec 31, 20240.0%+5.0 ptsQ3 2026 Reconciliation of Financial Information ↗
FY2023Dec 31, 2023-5.0%-5.0 ptsQ3 2026 Reconciliation of Financial Information ↗
FY2022Dec 31, 20220.0%-17.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
FY2021Dec 31, 202117.0%–Q4 & FY2024 Reconciliation of Financial Information ↗

Breakdown

What makes up consolidated Organic Revenue Growth

Cite this data

StockData. (2026). Thermo Fisher Scientific Consolidated Organic Revenue Growth (%), annual FY2021–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-bridge-organic-pct

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.